Brain Mitochondrial Drug Delivery: Influence of Drug Physicochemical Properties
- 303 Downloads
To determine the influence of drug physicochemical properties on brain mitochondrial delivery of 20 drugs at physiological pH.
The delivery of 8 cationic drugs (beta-blockers), 6 neutral drugs (corticosteroids), and 6 anionic drugs (non-steroidal anti-inflammatory drugs, NSAIDs) to isolated rat brain mitochondria was determined with and without membrane depolarization. Multiple linear regression was used to determine whether lipophilicity (Log D), charge, polarizability, polar surface area (PSA), and molecular weight influence mitochondrial delivery.
The Log D for beta-blockers, corticosteroids, and NSAIDs was in the range of −1.41 to 1.37, 0.72 to 2.97, and −0.98 to 2, respectively. The % mitochondrial uptake increased exponentially with an increase in Log D for each class of drugs, with the uptake at a given lipophilicity obeying the rank order cationic>anionic>neutral. Valinomycin reduced membrane potential and the delivery of positively charged propranolol and betaxolol. The best equation for the combined data set was Log % Uptake = 0.333 Log D + 0.157 Charge – 0.887 Log PSA + 2.032 (R2 = 0.738).
Drug lipopohilicity, charge, and polar surface area and membrane potential influence mitochondrial drug delivery, with the uptake of positively charged, lipophilic molecules being the most efficient.
KEY WORDSbrain delivery lipophilicity membrane potential mitochondrial delivery polar surface area
2′ 3′-cyclic nucleotide 3′-phosphodiesterase
explained variance/unexplained variance
590 nm emission/525 nm emission
liquid chromatography tandem mass spectrometry
- Log D
Log distribution coefficient
- Log P
Log partition coefficient
number of molecules
non-steroidal anti-inflammatory drugs
acid dissociation constant
polar surface area
amount of variance in dependent variable that is explained by model
standard error of the estimate
ACKNOWLEDGMENTS & DISCLOSURES
This work was supported in part by the NIH grants R01EY018940 (UBK), R01EY017533 (UBK), R01NS45748 (MP) and R01NS039587 (MP).
- 3.Geromel V, Kadhom N, Cebalos-Picot I, Ouari O, Polidori A, Munnich A, et al. Superoxide-induced massive apoptosis in cultured skin fibroblasts harboring the neurogenic ataxia retinitis pigmentosa (NARP) mutation in the ATPase-6 gene of the mitochondrial DNA. Hum Mol Genet. 2001;10(11):1221–8.PubMedCrossRefGoogle Scholar
- 8.Neroev V, Archipova M, Bakeeva L, Fursova A, Grigorian E, Grishanova A, et al. Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 4. Age-related eye disease. SkQ1 returns vision to blind animals. Biochemistry (Moscow). 2008;73(12):1317–28.CrossRefGoogle Scholar
- 10.Kamo N, Muratsugu M, Hongoh R, Kobatake Y. Membrane potential of mitochondria measured with an electrode sensitive to tetraphenyl phosphonium and relationship between proton electrochemical potential and phosphorylation potential in steady state. J Membr Biol. 1979;49(2):105–21.PubMedCrossRefGoogle Scholar
- 27.Garg P, Verma J, Roy N. In silico modeling for blood—brain barrier permeability predictions. Springer US: Drug Absorption Studies; 2008. p. 510–56.Google Scholar